Bristol Myers Squibb (BMY) Payables (2009 - 2026)
Bristol Myers Squibb (BMY) reported Payables of $4.16 billion for Q2 2026, down 23.4% from $5.43 billion a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Payables of $3.58 billion, down 0.7% from FY2024.
- Payables has a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- By year, Payables came in at $3.6 billion in FY2024 (+10.5%), $3.26 billion in FY2023 (+7.2%), $3.04 billion in FY2022 (+3.1%) and $2.95 billion in FY2021 (+8.7%).
- Five-year quarterly Payables spans a low of $2.6 billion in Q3 2022 and a high of $5.43 billion in Q2 2025.
- Year over year, Payables gained in six of the last eight quarters, with growth averaging 12.1%.
- The high point for year-over-year Payables in five years was Q2 2025 (growth of 44.7%); the low point was Q2 2026 (a decline of 23.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.23 billion (Q1 2026), $3.58 billion (Q4 2025) and $4.29 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Bristol Myers Squibb | 126.07 Bn | 77.35 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.16 Bn |
| Mar 31, 2026 | 4.23 Bn |
| Dec 31, 2025 | 3.58 Bn |
| Sep 30, 2025 | 4.29 Bn |
| Jun 30, 2025 | 5.43 Bn |
| Mar 31, 2025 | 4.00 Bn |
| Dec 31, 2024 | 3.60 Bn |
| Sep 30, 2024 | 3.47 Bn |
| Jun 30, 2024 | 3.75 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 3.26 Bn |
| Sep 30, 2023 | 2.81 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.04 Bn |
| Sep 30, 2022 | 2.60 Bn |
| Jun 30, 2022 | 2.88 Bn |
| Mar 31, 2022 | 2.94 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 2.70 Bn |
API Access
Bristol Myers Squibb Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();